⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Pomerantz LLP Notifies Investors of Class Action Lawsuit Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX 9-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
globenewswire.com
MLTX
MLTX SECURITIES ALERT: BFA Law Reminds MoonLake Immunotherapeutics Investors with Losses of Important December 15 Securities Class Action Deadline
newsfilecorp.com
MLTX
התראת מועד חשוב לתביעה נגד MLTX: רוזן, עורכי דין מקצועיים למשפטים, מעודדים את משקיעי MoonLake Immunotherapeutics להשיג ייעוץ משפטי לפני המועד החשוב של 15 בדצמבר בתביעה ייצוגית בניירות ערך – MLTX
globenewswire.com
MLTX
Pomerantz LLP Notifies Investors of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX
globenewswire.com
MLTX
Investors SueWallSt Over MoonLake Immunotherapeutics Stock Drop - Contact Levi & Korsinsky to Join
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Seeking Recovery for Investors - Contact Levi & Korsinsky
prnewswire.com
MLTX
MLTX DEADLINE ALERT: MoonLake Immunotherapeutics Securities Fraud Deadline is December 15 - Investors With Losses Urged to Contact BFA Law
accessnewswire.com
MLTX
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
globenewswire.com
MLTX